DK131029B - Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.

Info

Publication number
DK131029B
DK131029B DK608568AA DK608568A DK131029B DK 131029 B DK131029 B DK 131029B DK 608568A A DK608568A A DK 608568AA DK 608568 A DK608568 A DK 608568A DK 131029 B DK131029 B DK 131029B
Authority
DK
Denmark
Prior art keywords
alkylaminopropanes
racemic
phenoxy
hydroxy
preparation
Prior art date
Application number
DK608568AA
Other languages
English (en)
Other versions
DK131029C (da
Inventor
H Koppe
W Kummer
H Stehle
K Zeile
A Engelhardt
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of DK131029B publication Critical patent/DK131029B/da
Application granted granted Critical
Publication of DK131029C publication Critical patent/DK131029C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK608568AA 1967-12-13 1968-12-12 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf. DK131029B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1643262A DE1643262C3 (de) 1967-12-13 1967-12-13 i-Phenoxy^-hydroxy-S-alklyaminopropane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
DK131029B true DK131029B (da) 1975-05-20
DK131029C DK131029C (da) 1975-10-06

Family

ID=5684274

Family Applications (1)

Application Number Title Priority Date Filing Date
DK608568AA DK131029B (da) 1967-12-13 1968-12-12 Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.

Country Status (21)

Country Link
US (1) US3872147A (da)
JP (1) JPS5220457B1 (da)
AT (13) AT292673B (da)
BE (1) BE725490A (da)
BG (9) BG17298A3 (da)
BR (1) BR6804840D0 (da)
CA (1) CA954528A (da)
CH (2) CH556816A (da)
DE (1) DE1643262C3 (da)
DK (1) DK131029B (da)
ES (11) ES361189A1 (da)
FI (1) FI49497C (da)
FR (2) FR1596100A (da)
GB (1) GB1260866A (da)
HU (1) HU162734B (da)
IE (1) IE32758B1 (da)
IL (1) IL31266A (da)
NL (3) NL146709B (da)
PH (1) PH9266A (da)
SE (1) SE367396B (da)
YU (12) YU33949B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541130A (en) * 1967-02-06 1970-11-17 Boehringer Sohn Ingelheim 1-(cyanophenoxy)-2-hydroxy-3-tert.-butylamine propanes
US4086272A (en) * 1970-07-18 1978-04-25 Pfizer Inc. Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants
US3998874A (en) * 1971-03-23 1976-12-21 Gist-Brocades N.V. Phenylene di-ethers
US4038414A (en) * 1972-06-08 1977-07-26 Ciba-Geigy Corporation Amines and processes for their manufacture
DE2309887C2 (de) * 1973-02-28 1983-11-10 C.H. Boehringer Sohn, 6507 Ingelheim 1-Aryloxy-2-hydroxy-3-alkinylaminopropan-Derivate und deren physiologisch verträgliche Säureadditionssalze, pharmazeutische Präparate und Herstellungsverfahren für die Verbindungen
US4084002A (en) * 1973-02-28 1978-04-11 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing a 1-phenoxy-2-hydroxy-3-alkynylamino-propane and method of use
US4161530A (en) * 1975-01-06 1979-07-17 Ciba-Geigy Corporation Pharmaceutical combination preparations as hypnotics
US4094991A (en) * 1975-06-17 1978-06-13 Nippon Shinyaku Co., Ltd. Substituted n-(carboxymethyl)-3-aminopropan-2-ol derivatives
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
DE2839475A1 (de) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Isopropylamin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
EP0025331B1 (en) * 1979-09-06 1983-03-02 Beecham Group Plc Cinnamic acid derivatives, their preparation, and pharmaceutical compositions containing them
JPS56142262A (en) 1980-04-08 1981-11-06 Nippon Shinyaku Co Ltd Piperazine derivative
US4593119A (en) * 1980-11-28 1986-06-03 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4405642A (en) * 1980-11-28 1983-09-20 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
US4396629A (en) * 1980-12-29 1983-08-02 Sterling Drug Inc. Compositions, processes and method
DE3131527A1 (de) * 1981-08-08 1983-02-24 Kali-Chemie Pharma Gmbh, 3000 Hannover 1-phenyl-2-aminocarbonylindol-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU575153B2 (en) * 1984-04-09 1988-07-21 Du Pont Merck Pharmaceutical Company, The Pharmaceutical compositions and method for treatment for prophylaxis of cardiac disorders
US4652584A (en) * 1984-07-13 1987-03-24 Mcneilab, Inc. Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure
US4945182A (en) * 1985-12-24 1990-07-31 Merck & Co., Inc. Oculoselective beta-blockers
ATE45724T1 (de) * 1985-12-24 1989-09-15 Merck & Co Inc Okuloselektive betablocker.
US5480908A (en) * 1993-12-13 1996-01-02 American Cyanamid Company β3 -adrenergic agents benzodioxole dicarboxylates and their use in pharmaceutical compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459782A (en) * 1963-08-26 1969-08-05 Boehringer Sohn Ingelheim 1-substituted phenoxy-2-hydroxy-3-isopropylamino-propanes

Also Published As

Publication number Publication date
YU237974A (en) 1977-12-31
ES375445A1 (es) 1972-05-16
DE1643262B2 (de) 1974-11-07
NL146709B (nl) 1975-08-15
FI49497C (fi) 1975-07-10
YU33773B (en) 1978-05-15
NL6817768A (da) 1969-06-17
ES375444A1 (es) 1972-05-01
ES375450A1 (es) 1972-05-01
YU33856B (en) 1978-06-30
YU33851B (en) 1978-06-30
JPS5220457B1 (da) 1977-06-03
ES375448A1 (es) 1972-05-01
YU238074A (en) 1977-12-31
FR8328M (da) 1970-12-07
YU294968A (en) 1978-02-28
YU237874A (en) 1977-12-31
ES375452A1 (es) 1972-05-16
YU33855B (en) 1978-06-30
YU33949B (en) 1978-09-08
AT294799B (de) 1971-12-10
DK131029C (da) 1975-10-06
YU33948B (en) 1978-09-08
ES375451A1 (es) 1972-05-01
BG16331A3 (bg) 1972-08-20
AT292676B (de) 1971-09-10
AT292680B (de) 1971-09-10
BE725490A (da) 1969-06-13
YU33853B (en) 1978-06-30
AT292674B (de) 1971-09-10
BG16330A3 (bg) 1972-08-20
BG17298A3 (bg) 1973-07-25
BG16332A3 (bg) 1972-08-20
AT292670B (de) 1971-09-10
NL7501794A (nl) 1975-05-30
PH9266A (en) 1975-07-30
DE1643262A1 (de) 1972-04-20
AT292675B (de) 1971-09-10
ES361189A1 (es) 1970-08-16
YU237574A (en) 1978-02-28
IE32758L (en) 1969-06-13
YU238474A (en) 1978-02-28
SE367396B (da) 1974-05-27
YU237774A (en) 1978-02-28
US3872147A (en) 1975-03-18
IL31266A (en) 1974-09-10
AT292678B (de) 1971-09-10
AT292673B (de) 1971-09-10
DE1643262C3 (de) 1975-06-26
YU237674A (en) 1977-10-31
YU238374A (en) 1977-12-31
BR6804840D0 (pt) 1973-03-08
YU33854B (en) 1978-06-30
YU237474A (en) 1977-12-31
ES375447A1 (es) 1972-05-01
BG16329A3 (bg) 1972-08-20
CH556816A (de) 1974-12-13
ES375453A1 (es) 1972-05-16
IL31266A0 (en) 1969-02-27
GB1260866A (en) 1972-01-19
AT298459B (de) 1972-05-10
YU33774B (en) 1978-05-15
HU162734B (da) 1973-04-28
FR1596100A (da) 1970-06-15
NL151354B (nl) 1976-11-15
AT292679B (de) 1971-09-10
ES375449A1 (es) 1972-05-01
YU33947B (en) 1978-09-08
AT292681B (de) 1971-08-15
BG19135A3 (bg) 1975-04-30
FI49497B (da) 1975-04-01
ES375446A1 (es) 1972-05-01
BG16444A3 (bg) 1972-11-20
NL7501792A (nl) 1975-05-30
YU238274A (en) 1977-12-31
YU33852B (en) 1978-06-30
YU238174A (en) 1977-10-31
AT298463B (de) 1972-05-10
CA954528A (en) 1974-09-10
AT292677B (de) 1971-09-10
BG17297A3 (bg) 1973-07-25
BG16445A3 (bg) 1972-11-20
CH532015A (de) 1972-12-31
YU33946B (en) 1978-09-08
IE32758B1 (en) 1973-11-28

Similar Documents

Publication Publication Date Title
DK131029B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-alkylaminopropaner eller syreadditionssalte deraf.
DK129447B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-sek.-alkylaminopropaner eller syreadditionssalte heraf.
DK123022B (da) Analogifremgangsmåde til fremstilling af amino-monohalogen-phenylethanolaminer eller syreadditionssalte deraf.
DK120756B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive norscopolaminderivater eller syreadditionssalte eller kvaternære salte heraf.
DK136527B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive p-alkoxyfenoxypropanolaminer eller syreadditionssalte deraf.
DK140281B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 1-phenoxy-2-hydroxy-3-cycloalkylaminopropaner eller syreadditionssalte heraf.
DK122133B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK121512B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 5-phenyl-6,7-benzomorphaner eller syreadditionssalte deraf.
DK124081B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive piperazinderivater eller syreadditionssalte deraf.
DK131935B (da) Analogifremgangsmåde til fremstilling af aminoalkynyllaktamforbindelser eller syreadditionssalte deraf.
DK125639B (da) Analogifremgangsmåde til fremstilling af racemisk eller optisk aktivt 1-(2-nitrilophenoxy)-2-hydroxy-3-ethylaminopropan eller syreadditionssalte heraf.
DK131988B (da) Analogifremgangsmåde til fremstilling af optisk aktive eller racemiske 1-aryloxy-2-hydroxy-3-isopropylamino-propaner eller syreadditionssalte heraf.
DK139582B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive benzocycloheptaisoquinolin-forbindelser eller syreadditionssalte deraf.
DK129235B (da) Fremgangsmåde til fremstilling af racemiske eller optisk aktive quinolinderivater eller syreadditionssalte deraf.
DK129699B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 9,10-dihydro-9,10-ethano-anthracener eller syreadditionssalte deraf.
DK130587B (da) Analogifremgangsmåde til fremstilling af difenylpyridazoner eller syreadditionssalt deraf.
DK137674B (da) Analogifremgangsmåde til fremstilling af monophenylsubstituerede oxazoler eller syreadditionssalte deraf.
DK126781B (da) Analogifremgangsmåde til fremstilling af pyrrolidinoguanidinforbindelser eller syreadditionssalte deraf.
DK121513B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive N-substituerede noratropiniumsalte.
DK131670B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive alfa-substituerede 2-amino-methyl-benzylalkoholer eller syreadditionssalte heraf.
DK135128B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive estre af alfa-aminobenzylpenicillin.
DK132551B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive carbamoylalkoxyphenoxyisopropanolaminderivater eller syreadditionssalte deraf.
DK128813B (da) Analogifremgangsmåde til fremstilling af basisk substituerede thiophthalaner eller syreadditionssalte deraf.
DK131281B (da) Analogifremgangsmåde til fremstilling af erythro- eller threo-alfa-(1-aminoethyl)-benzylalkohol-3-ethere eller syreadditionssalte heraf eller de tilsvarende optisk aktive forbindelser.
DK128237B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive N-alkyl-substituerede (2-cyano-5-methylphenoxy)-propanolaminer eller fysiologisk acceptable syreadditionssalte deraf.

Legal Events

Date Code Title Description
PBP Patent lapsed